Skip to main content
TipRanks
Go Ultimate75% OFF

COSMO Pharmaceuticals N.V. (C43) Stock Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

C43 Analyst Ratings

Currently, no data available

C43 Stock 12 Month Forecast

There Are No Analyst Ratings for C43 In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:C43
Price TargetArticle
Jefferies€120.03buy92.36%UpsideReiterated07/28/26
Berenberg Bank Analyst forecast on DE:C43Unknown AnalystNot RankedBerenberg Bank€130.94buy109.84%UpsideReiterated07/27/26
Kepler Capital €141.85buy127.33%UpsideReiterated05/11/26
H.C. Wainwright€174.59buy179.79%UpsideReiterated04/20/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering COSMO Pharmaceuticals N.V.

3 Months
Nicolas Pauillac
Nicolas PauillacKepler Capital
Success Rate13/21 ratings generated profit
62%
Average Return
+5.56%

Copying Nicolas Pauillac's trades and holding each position for 3 Months would result in 61.90% of your transactions generating a profit, with an average return of +5.56% per trade.

1 Year
Nicolas Pauillac
Nicolas PauillacKepler Capital
Success Rate10/21 ratings generated profit
48%
Average Return
+12.50%

Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +12.50% per trade.

2 Years
Nicolas Pauillac
Nicolas PauillacKepler Capital
Success Rate9/21 ratings generated profit
43%
Average Return
+6.68%

Copying Nicolas Pauillac's trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of +6.68% per trade.

C43 Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for C43
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy42200
Buy00000
Hold00000
Sell00000
Strong Sell00000
total42200

In the current month, C43 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. C43 average Analyst price target in the past 3 months is ―.

C43 Financial Forecast

€-2€-0.5€1€2.5€4Q2 2025Q2 2026Q4 2026
Consensus€-0.28

C43 Earnings Forecast

Next quarter’s earnings estimate for C43 is -EUR 0.28 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.28. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

€49M€69.5M€90M€110.4M€130.9MQ2 2025Q2 2026Q4 2026
Consensus€49M

C43 Sales Forecast

Next quarter’s sales forecast for C43 is EUR 49.00M with a range of ― to ―. The previous quarter’s sales results were EUR 49.00M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

C43 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about COSMO Pharmaceuticals N.V.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of COSMO Pharmaceuticals N.V.?
To buy shares of DE:C43, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.